Mitsuru Sakakibara

1.2k total citations
33 papers, 932 citations indexed

About

Mitsuru Sakakibara is a scholar working on Hepatology, Immunology and Epidemiology. According to data from OpenAlex, Mitsuru Sakakibara has authored 33 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 15 papers in Immunology and 13 papers in Epidemiology. Recurrent topics in Mitsuru Sakakibara's work include Immune Cell Function and Interaction (10 papers), Hepatitis C virus research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Mitsuru Sakakibara is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Hepatitis C virus research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Mitsuru Sakakibara collaborates with scholars based in Japan and United States. Mitsuru Sakakibara's co-authors include Norio Hayashi, Tetsuo Takehara, Tatsuya Kanto, Naoki Hiramatsu, Takayuki Yakushijin, Akinori Kasahara, Ichiyo Itose, Hideki Miyatake, Michiyo Inoue and Masanori Miyazaki and has published in prestigious journals such as Hepatology, Cancer and The Journal of Infectious Diseases.

In The Last Decade

Mitsuru Sakakibara

31 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuru Sakakibara Japan 16 481 457 320 173 142 33 932
Xiumei Chi China 18 512 1.1× 213 0.5× 504 1.6× 175 1.0× 70 0.5× 53 917
K Mitamura Japan 14 318 0.7× 130 0.3× 263 0.8× 259 1.5× 114 0.8× 45 909
John Napoli Australia 10 471 1.0× 180 0.4× 376 1.2× 87 0.5× 157 1.1× 14 795
Narayan Dharel Japan 13 315 0.7× 150 0.3× 309 1.0× 190 1.1× 120 0.8× 19 645
Mirko Moreno Zaldivar Germany 9 434 0.9× 191 0.4× 427 1.3× 151 0.9× 141 1.0× 10 801
Akihiro Furusaka Japan 11 852 1.8× 93 0.2× 770 2.4× 314 1.8× 68 0.5× 16 1.1k
Sk. Md. Fazle Akbar Japan 18 318 0.7× 486 1.1× 419 1.3× 118 0.7× 98 0.7× 27 864
Takashi Ohkawa Japan 11 178 0.4× 513 1.1× 179 0.6× 134 0.8× 103 0.7× 13 893
P H McGuinness Australia 6 537 1.1× 165 0.4× 413 1.3× 64 0.4× 51 0.4× 9 688
R González-Amaro Spain 9 106 0.2× 188 0.4× 174 0.5× 108 0.6× 65 0.5× 10 570

Countries citing papers authored by Mitsuru Sakakibara

Since Specialization
Citations

This map shows the geographic impact of Mitsuru Sakakibara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Sakakibara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Sakakibara more than expected).

Fields of papers citing papers by Mitsuru Sakakibara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Sakakibara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Sakakibara. The network helps show where Mitsuru Sakakibara may publish in the future.

Co-authorship network of co-authors of Mitsuru Sakakibara

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuru Sakakibara. A scholar is included among the top collaborators of Mitsuru Sakakibara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuru Sakakibara. Mitsuru Sakakibara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamori, Ryotaro, Yuki Tahata, Yasutoshi Nozaki, et al.. (2022). Prognostic impact of worsening of esophageal varices after balloon‐occluded retrograde transvenous obliteration. Journal of Gastroenterology and Hepatology. 37(6). 1148–1155.
2.
Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2021). Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment. Hepatology Research. 51(5). 517–527. 3 indexed citations
3.
Ohkawa, Kazuyoshi, Mitsuru Sakakibara, Takatoshi Nawa, et al.. (2020). Prognostic Factors for Patients With a Large Number of Hepatocellular Carcinoma Nodules. Journal of Clinical Medicine Research. 12(1). 26–35. 2 indexed citations
4.
Nawa, Takatoshi, Kazuhiro Katayama, Noriko Hasegawa, et al.. (2019). Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma. Clinical Journal of Gastroenterology. 13(2). 247–251.
5.
Sakakibara, Mitsuru, et al.. (2018). Two-step progression of varenicline-induced autoimmune hepatitis. Clinical Journal of Gastroenterology. 11(3). 184–187. 1 indexed citations
6.
Katayama, Kazuhiro, Kozo Takahashi, Yuko Taniguchi, et al.. (2017). The Effectiveness of a Liver Disease Education Class for Providing Information to Patients and Their Families. Journal of Clinical Medicine Research. 9(3). 207–212. 9 indexed citations
7.
Imai, Yasuharu, Kazuhiro Katayama, Masatoshi Hori, et al.. (2017). Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation. Liver Cancer. 6(4). 349–359. 31 indexed citations
8.
Ohkawa, Kazuyoshi, Masanori Miyazaki, Mitsuru Sakakibara, et al.. (2016). Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers. Hepatology International. 11(1). 105–114. 40 indexed citations
9.
Matsubara, Tokuhiro, Tatsuya Kanto, Shoko Kuroda, et al.. (2012). TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Hepatology. 57(4). 1416–1425. 117 indexed citations
10.
Kakita, Naruyasu, Tatsuya Kanto, Ichiyo Itose, et al.. (2012). Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: A crucial role of CD25FOXP3 T cells. International Journal of Cancer. 131(11). 2573–2583. 18 indexed citations
11.
Katayama, Kazuhiro, Mitsuru Sakakibara, Kazuho Imanaka, et al.. (2011). Effect of zinc supplementation in patients with type C liver cirrhosis. Open Journal of Gastroenterology. 1(2). 28–34. 11 indexed citations
12.
Kanto, Tatsuya, Michiyo Inoue, Tsugiko Oze, et al.. (2011). Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients. Journal of Gastroenterology. 47(2). 169–178. 9 indexed citations
13.
Sakakibara, Mitsuru, Tatsuya Kanto, Shoko Kuroda, et al.. (2011). Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide. Cancer Immunology Immunotherapy. 60(11). 1565–1575. 30 indexed citations
14.
Miyazaki, Masanori, Tatsuya Kanto, Michiyo Inoue, et al.. (2008). Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll‐like receptors and retinoic acid inducible gene‐I. Journal of Medical Virology. 80(6). 980–988. 57 indexed citations
15.
Itose, Ichiyo, Tatsuya Kanto, Michiyo Inoue, et al.. (2007). Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon‐α and ribavirin therapy for chronic hepatitis C patients. Journal of Medical Virology. 79(5). 511–521. 11 indexed citations
16.
Miyatake, Hideki, Tatsuya Kanto, Machiko Inoue, et al.. (2006). Impaired ability of interferon‐alpha‐primed dendritic cells to stimulate Th1‐type CD4 T‐cell response in chronic hepatitis C virus infection. Journal of Viral Hepatitis. 14(6). 404–412. 21 indexed citations
17.
Inoue, Michiyo, Tatsuya Kanto, Hideki Miyatake, et al.. (2006). Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection. Journal of Hepatology. 45(2). 190–196. 23 indexed citations
18.
Kanto, Tatsuya, Michiyo Inoue, Masanori Miyazaki, et al.. (2005). Impaired Function of Dendritic Cells Circulating in Patients Infected with Hepatitis C Virus Who Have Persistently Normal Alanine Aminotransferase Levels. Intervirology. 49(1-2). 58–63. 47 indexed citations
19.
Kanto, Tatsuya, Michiyo Inoue, Hideki Miyatake, et al.. (2004). Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. 190(11). 1919–1926. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026